BELLADERM Trademark

Trademark Overview

On Monday, March 31, 2025, a trademark application was filed for BELLADERM with the United States Patent and Trademark Office. The USPTO has given the BELLADERM trademark a serial number of 99112691. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, June 16, 2026. This trademark is owned by MUSCULOSKELETAL TRANSPLANT FOUNDATION. The BELLADERM trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
belladerm

General Information

Serial Number99112691
Word MarkBELLADERM
Filing DateMonday, March 31, 2025
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, June 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 30, 2025

Trademark Statements

Goods and ServicesHuman allograft tissue

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 31, 2025
Primary Code005
First Use Anywhere DateTuesday, September 30, 2025
First Use In Commerce DateTuesday, September 30, 2025

Trademark Owner History

Party NameMUSCULOSKELETAL TRANSPLANT FOUNDATION
Party Type20 - Owner at Publication
Legal Entity Type54 - NOT AVAILABLE
AddressEdison, NJ 08837
US
Party NameMUSCULOSKELETAL TRANSPLANT FOUNDATION
Party Type10 - Original Applicant
Legal Entity Type54 - NOT AVAILABLE
AddressEdison, NJ 08837
US

Trademark Events

Event DateEvent Description
Monday, March 31, 2025NEW APPLICATION ENTERED
Monday, March 31, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 31, 2025APPLICATION FILING RECEIPT MAILED
Thursday, August 28, 2025ASSIGNED TO EXAMINER
Thursday, August 28, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 24, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 30, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 30, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 25, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 5, 2026TEAS STATEMENT OF USE RECEIVED
Monday, January 5, 2026USE AMENDMENT FILED
Tuesday, May 12, 2026STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 16, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 16, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

belladerm tissue allograft human